Blog - Page 2959 of 5591

TuesdayApr 02, 2013 10:28 am

The Aristocrat Group Corp. (ASCC) Leveraging Cocktail of Marketing Strategies to Promote New Vodka Lines

The Aristocrat Group Corp. today gave a broad overview of its strategy to capitalize on the fast-growing super-premium vodka segment, which has increased 32 percent in the last two years to $1.2 billion. Vodka, which accounts for 32 percent of industry volume, increased 5.9 percent in 2011 and now counts for a third of all spirits consumed in America. ASCC’s brand management division, Luxuria Brands, is constructing a marketing strategy that will position ASCC as a competitive player in the highly lucrative beverage industry, honing a specific focus on vodka branding and marketing. As ASCC executes its plan to introduce…

TuesdayApr 02, 2013 10:26 am

Cord Blood America, Inc. (CBAI) Posts FY2012 Financial Results, Offers Favorable View for 2013

Cord Blood America reported its full-year 2012 financial results for the 12 months ended December 31, 2012, reflecting a revamped business model. Revenues for 2012 clipped a record $6.0 million, up 18 percent from $5.1 million reported in the year-ago period. Gross profit for the year increased by 20 percent to $4.20 million from $3.5 million reported in the comparable period of 2011. Administrative and selling expenses for the year decreased by 17 percent to $5.63 million, compared to $6.75 million for the year prior. Positive cash flow from operations increased 117 percent to $0.19 million vs. the year ago…

TuesdayApr 02, 2013 10:25 am

Cellceutix Corp. (CTIX) Announces Selection of Kevetrin™ Abstract for Poster Presentation at 2013 ASCO Meeting

Cellceutix, a clinical stage biopharmaceutical company driving towards the discovery of small molecule drugs for the treatment of unmet medical conditions, announced that its abstract on Kevetrin™, the company’s flagship cancer drug candidate currently in clinical trials at Dana-Farber Cencer Center and Beth Israel Deaconess, will be a part of the poster presentation at the 2013 American Society of Clinical Oncology (“ASCO”) Annual Meeting. The annual ASCO meeting is from May 31 through June 4, 2013, in Chicago, Illinois. The “General Poster Session: Developmental Therapeutics - Clinical Pharmacology and Experimental Therapeutics” portion of the symposium will feature Cellceutix’s abstract titled,…

TuesdayApr 02, 2013 9:22 am

Loans4Less.com, Inc. (LFLS) Reports Anticipation of Becoming Fully Reporting by 2014

Loans4Less.com, a publicly traded online mortgage loan brokerage focused on Conforming loans, today announced that it is on target to become a fully reporting company next year. The company’s Annual Report & Audited Financials for 2012 have been posted at www.otcmarkets.com/stock/LFLS/filings. The online mortgage loan brokerage also reported initiatives to ink licensing and/or joint-venture arrangements as well as possibly pursue other loan products to rebrand Loans4Less.com as a general loan consumer portal while continuing to offer mortgages as its base service. Steven M. Hershman, Chairman & President, commented, "We are excited to be on track to become a fully reporting…

TuesdayApr 02, 2013 8:53 am

Rainbow Coral Corp. (RBCC) Launches New Website, Highlights Impressive Deal Flow

Last week, Rainbow BioSciences, the biotechnology division of Rainbow Coral Corp., revealed a new website highlighting its explorations into the multi-billion-dollar drug delivery and genome-mapping market. The new website replaces the prior version and can be found at www.rainbowbiosciences.com. The revamped site details the company’s new partnership with TheraKine Ltd., the developer of a revolutionary, sustained-release drug delivery platform that could soon make local delivery of biologic agents and small molecules safer, more effective, and more convenient than ever before. Some experts believe that the worldwide market for the 10 most popular drug delivery technologies (DDTs) alone could grow to…

MondayApr 01, 2013 3:53 pm

GlobalWise Investments, Inc. (GWIV) Merges Two Powerhouse Technologies

The story of Intellinetics, subsidiary of GlobalWise Investments, is one of technological convergence, and reflects the growth of information processing and communication over the past 20 years. On one hand, there is the development of ECM (Enterprise Content Management), the digital capture and storage of an organization’s documents for effective access, exemplified by Intellinetics and its lead product Intellivue. On the other hand, you have the burgeoning world of data communications, with the Internet and increasingly capable mobile devices. Intellinetics began developing data storage solutions in the mid 1990s, about the time people began to realize that computerization was increasing…

MondayApr 01, 2013 2:42 pm

Dejour Energy, Inc. (DEJ) Spuds First of Three New Piceance Basin Wells at Kokopelli

Dejour Energy is drilling again on their Kokopelli field development project in Colorado's Piceance Basin, where the company has some 129k net acres total (another 8.5k net acres over in the Peace River Arch), as news drops today that well one of three in the new drilling program, a directional well named Federal 6-7-15-27, was successfully spud last week. Drilling is slated for next week and surface casings are all set to be put in on the remaining 14-27 and 13-27 wells. DEJ has projected a 30-day window for the job, which will also include logging/casing down to around 8.3k…

MondayApr 01, 2013 2:05 pm

Cardium Therapeutics, Inc. (CXM) Addresses the High Cost of Heart Surgery

The number and degree of medical advances over the past 50 years is astonishing, offering hope for the afflicted never before possible or even imaginable. But it’s hope that comes with a very steep price. Regardless of who pays the bill, or how efficiently everything is administered, the cost of applying the latest technologies is going to be high, whether in the form of drugs, diagnostic instrumentation, or complex surgeries. As existing technologies mature, costs can decrease, but the use of mature technologies is inevitably replaced by a demand for even newer drugs, instrumentation, and procedures. When a loved one’s…

MondayApr 01, 2013 12:05 pm

Cryoport, Inc. (CYRX) Adds Member to Board of Directors

Cryoport provides cutting-edge frozen shipping services to the life sciences industry. It does so through a combination of purpose-built proprietary technologies and total turnkey management of the entire logistics process. The company's service management approach offers reliability, cost effectiveness, and convenience. The company announced today that it appointed Richard G. Rathmann to Cryoport's Board of Directors. With this addition to its Board, Cryoport now consists of five members, four of which are independent, including Mr. Rathmann. Mr. Rathmann is an experienced venture fund manager and advisor to life science companies. He is currently the manager of GBR Investments LLC and…

MondayApr 01, 2013 10:59 am

The Guitammer Company, Inc. (GTMM) Launches Music into a New Dimension

When it comes to music, nobody takes things more seriously than professional musicians, the people whose livelihood depends upon getting it right. They’re passion for the music experience is what drives them, and, of course, it’s also what drives their fans. So when you have a creative new product designed to add a new dimension to that experience, and it has already been picked up by 100 of the world’s top bands and performers, names like the Rolling Stones and Shania Twain and Usher, you know you’ve hit a chord. Such is the case with the ButtKicker Concert, Guitammer’s patented…

Site Search

Company Search